Cystic Fibrosis 2 Flashcards

1
Q

what patient population with CF do you use high dose ibuprofen in?

A

patients that are under 18 year old with FEV1 > 60%

Patients over 18 years old – Evidence insufficient to recommend for or against chronic use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The effect of high dose ibuprofen is a lower decline in which systems function?

A

pulmonary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

benefits of high dose ibuprofen exceed the risk of what

A

GI complications and. nephrotoxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

high dose ibuprofen allows for patients to maintain weight and leads to less what?

A

hospital admission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

for those taking high dose ibuprofen what must be monitored with blood draws?

A

if the patient is at a specific therapeutic level of ibuprofen (pharmacokinetic monitoring)
Target 50-100 μg/ml

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

one MOI for Anti-inflammatory Therapy-Ibuprofen is to reversibly inhibits cyclooxygenase-1 and 2 (COX-1 and 2) enzymes, what does his lead to?

A

decreased formation of prostaglandin precursors

it is an antipyretic, analgesic, and has anti-inflammatory properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

other mechanisms for Anti-inflammatory Therapy-Ibuprofen are?

A

inhibiting chemotaxis
altering lymphocyte activity
inhibiting neutrophil aggregation/activation
decreasing proinflammatory cytokine levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anti-inflammatory Therapy-Ibuprofen ADEs

A

edema, headache, fluid retention, epigastric pain, gi bleed, tinnitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lumacaftor is usually used in combination with what drug?

A

Ivacaftor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Ivacaftor MOI

A

Improves the gating abnormality, effects G551D mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Pancreatic Enzyme Supplementation ADEs

A

cause ulcers in oral mucosa after prolonged contact

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pancreatic Enzyme Supplementation should be administered with

A

food, and mouth should be rinded after administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Excessive doses of pancreatic enzymes can cause what?

A

fibrosing colonopathy, characterized by inflammation and strictures

risk reduced by limiting dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pancreatic Enzyme
Replacement Therapy
Dose is calculated using which units?

A

Lipase units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

______ insufficiency affects up to 85% of patients in their lifetime

A

pancreatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

_______ lipase units per kilogram (kg) of body weight per meal
or ______ units per kg per day

A

500 to 2,500 lipase units per kilogram (kg) of body weight per meal
or 10,000 units per kg per day

17
Q

which disease is 6 to 8 times more common in CF children in whose without CF

A

Gastroesophageal Reflux Disease

18
Q

Omeprazole is which type of drug?

A

a proton pump inhibitor
that act by irreversibly blocking the hydrogen/potassium adenosine triphosphatase enzyme system

also called H+/K+ ATPase, or more commonly, the gastric proton pump

19
Q

Omeprazole ADEs

A

acid regurgitation, constipation, back pain, weakness, cough

20
Q

People with 2 copies of which mutation represent the largest group of people with CF?

A

F508del mutation

21
Q

Patients treated with lumacaftor/ivacaftor experienced statistically significant improvements in which function?

A

lung function

22
Q

patients with CF taking Lumacaftor/Ivacaftor also experienced what two benefits?

A

reductions in pulmonary exacerbations and improvements in body mass index

23
Q

nasopharyngitis is an ADE of which drug in more than 10% of patients?

A

lumacaftor/Ivacaftor

24
Q

ADEs experienced by 1 to 10% of patients taking lumacaftor/Ivacaftor?

A

fatigue, menstrual disease, Increased creatine phosphokinase, Upper respiratory tract infection, rhinorrhea

25
Q

G542X mutation

A

no synthesis of CFTR

26
Q

F508del mutation

A

reduced trafficking of CFTR

CFTR is misprocessed in ER

27
Q

G551D mutation

A

reduced gating of CFTR

unstable at membrane

28
Q

he CFTR gene is mutated, this function is

A

impaired and ions cannot be transported across membrane

29
Q

in when ions cannot be transported across membrane what are the results

A

higher electrolyte concentration inside the cell and water stays there, causing mucus to get thicker can block channels of the lung, Leads to Obstruction, Infection, and Inflammation

30
Q

Normally the CFTR’s function is to what?

A

to transport chloride ions from the inside of the cell to the outside, creates negative charge on the outside of the cell allowing positively charged sodium ions to follow charge out and water follows this makes mucus thinner

31
Q

Chromosome abnormality in CF

A

on chromosome 7 there are over 1750 mutations in the CFTR gene
accounts for 88% of the disease-causing alleles

32
Q

CFTR gene mutations result in various pathologies such as

A

primary lung disease to minor gastrointestinal (GI) involvement

33
Q

which class of mutations is most common in caucasians

A

class III , G551D, getting mutation

34
Q

Ivacaftor major interactions

A

Substrate of CYP3A4

35
Q

major Ivacaftor ADEs

A

headache, abdominal pain, nasopharngitis, hyperglycemia, Transaminases increased, arthralgia

36
Q

Tezacaftor/Ivacaftor should be taken with

A

fat containing food

37
Q

reduce Tezacaftor/Ivacaftor dose in those with

A
  • moderate and severe hepatic impairment

- or when co-administered with drugs that are moderate or strong CYP3A inhibitors

38
Q

what must be monitored in patients taking Tezacaftor/Ivacaftor

A

ALT and AST (every 3 months for the first year)

also monitor for any signs of cataract

39
Q

liver disease ADEs

A

Alopecia, leukopenia, thrombocytopenia, and serum creatinine increased